Compare Natera Inc. Common Stock (NTRA) vs Yum China Holdings Inc (YUMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Yum China Holdings Inc — how do they compare? Natera Inc. Common Stock trades at $393.93 (market cap $57.03B), while Yum China Holdings Inc trades at $43.53 (market cap $14.58B). The key difference: Natera Inc. Common Stock is far larger — about 3.9× Yum China Holdings Inc's market cap, and Yum China Holdings Inc pays a 2.69% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Yum China Holdings Inc for 77 Days on average.
| NTRA | YUMC | |
|---|---|---|
Market Cap | $57.03B | $14.58B |
Volume | 1,131,157 | 1,599,461 |
Sector | Health | Consumer Cyclical |
52-Week High | $425.64 | $57.95 |
52-Week Low | $179.42 | $39.98 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $56.18B | $15.49B |
Dividend Yield | — | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
YUMC trades at $43.11, up 0.63% today, with a bullish technical signal and strong analyst support (14 Buy, 5 Hold). The stock shows consistent earnings beats, with Q2 2026 EPS of $0.70 surpassing the $0.67 estimate. Revenue grew to $11.80B in 2025, and net income reached $929M. Recent corporate actions include a $0.29 dividend and the acquisition of Pizza Hut brand ownership in Mainland China, enhancing long-term growth prospects.
YUMC presents a favorable investment case with solid fundamentals, reasonable valuation (P/E 15.69), and positive earnings momentum. Key risks include competitive pressures in China's restaurant sector and macroeconomic sensitivity. Wall Street's average price target implies a 25.6% upside, supporting a bullish outlook for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Yum China Holdings Inc
With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →
